Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Here's Why Paycom Software (PAYC) is a Strong Value StockPhoto, wide shot, wide-angle lens,  Semiconductor company, sunset photo at golden hour, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/92ce44e9-64c7-4458-9a95-b706ed510490.png
Here's Why Paycom Software (PAYC) is a Strong Value Stock

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The popular research

Are Finance Stocks Lagging  Avidbank Holdings (AVBH) This Year?
Are Finance Stocks Lagging Avidbank Holdings (AVBH) This Year?

Investors interested in Finance stocks should always be looking to find the best-performing companies in the group. Is Avidbank Holdings Inc. (AVBH) one of those stocks right now? A quick glance at

Are Investors Undervaluing Methanex (MEOH) Right Now?
Are Investors Undervaluing Methanex (MEOH) Right Now?

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With

Buy These 5 Dividend Growth Stocks Amid AI Fear Disrupting MarketPhoto, wide shot, wide-angle lens,  Software company, sunset photo at golden hour, photo by Marc Adamus: https://img.theapi.app/temp/9d624ad0-0157-4808-b12c-caf136345180.png
Buy These 5 Dividend Growth Stocks Amid AI Fear Disrupting Market

Major U.S. stock market indices tumbled on Feb. 12, 2026, as fears about AI disruption spilled into sectors, such as real estate, transportation and software. Decline across all “Magnificent Seven”

Here's How Charles River Stock Is Placed Ahead of Q4 Earnings
Here's How Charles River Stock Is Placed Ahead of Q4 Earnings

Charles River Laboratories International, Inc. CRL is scheduled to report fourth-quarter 2025 results on Feb. 18, before the market opens.

In the last reported quarter, the company’s adjusted

SolarEdge Technologies to Post Q4 Earnings: Here's What to Expect
SolarEdge Technologies to Post Q4 Earnings: Here's What to Expect

SolarEdge Technologies SEDG is scheduled to release fourth-quarter 2025 results on Feb. 18, before market open. The company delivered an earnings surprise of 18.4% in the last reported quarter

Will ISRG's R&D Focus Following Solid Earnings Growth Drive Demand?
Will ISRG's R&D Focus Following Solid Earnings Growth Drive Demand?

After an impressive 2025, Intuitive Surgical ISRG remains focused on sustaining earnings strength while investing aggressively in its future. The company posted 22% pro forma earnings per share

Expedia Q4 Earnings & Revenues Beat Estimates, Both Increase Y/Y
Expedia Q4 Earnings & Revenues Beat Estimates, Both Increase Y/Y

Expedia Group EXPE reported fourth-quarter 2025 adjusted earnings of $3.78 per share, which surpassed the Zacks Consensus Estimate by 9.29%. The figure increased 58% year over year.Revenues of $3.55

Coca-Cola Hits 52-Week High: Should You Buy the Stock Now or Wait?
Coca-Cola Hits 52-Week High: Should You Buy the Stock Now or Wait?

The Coca-Cola Company KO reached a new 52-week high of $80.41 yesterday before dropping to close trading at $79.0, underscoring renewed investor confidence in the stock. This surge was largely

ETFs in Spotlight as Coinbase Lags Q4 Earnings & Revenue Estimates
ETFs in Spotlight as Coinbase Lags Q4 Earnings & Revenue Estimates

Shares of Coinbase Global, Inc. COIN swung wildly in the early hours of the after-hours trading session on Feb. 12 and then edged slightly higher (as cited in a Yahoo Finance excerpt) following the

Can Gilead's HIV Portfolio Sustain Its Growth Trend in 2026?
Can Gilead's HIV Portfolio Sustain Its Growth Trend in 2026?

Gilead Sciences, Inc. GILD has a market-leading HIV franchise, led by flagship HIV therapies — Biktarvy for treatment and Descovy for prevention.

Earlier this week, the company reported strong

Down 19.0% in 4 Weeks, Here's Why Cousins Properties (CUZ) Looks Ripe for a Turnaround
Down 19.0% in 4 Weeks, Here's Why Cousins Properties (CUZ) Looks Ripe for a Turnaround

Cousins Properties (CUZ) has been on a downward spiral lately with significant selling pressure. After declining 19% over the past four weeks, the stock looks well positioned for a trend reversal as

Down 20.9% in 4 Weeks, Here's Why Adtalem (ATGE) Looks Ripe for a Turnaround
Down 20.9% in 4 Weeks, Here's Why Adtalem (ATGE) Looks Ripe for a Turnaround

Adtalem Global Education (ATGE) has been on a downward spiral lately with significant selling pressure. After declining 20.9% over the past four weeks, the stock looks well positioned for a trend

Down 19.0% in 4 Weeks, Here's Why Waters (WAT) Looks Ripe for a Turnaround
Down 19.0% in 4 Weeks, Here's Why Waters (WAT) Looks Ripe for a Turnaround

Waters (WAT) has been beaten down lately with too much selling pressure. While the stock has lost 19% over the past four weeks, there is light at the end of the tunnel as it is now in oversold

Down 21.4% in 4 Weeks, Here's Why Health Catalyst (HCAT) Looks Ripe for a Turnaround
Down 21.4% in 4 Weeks, Here's Why Health Catalyst (HCAT) Looks Ripe for a Turnaround

A downtrend has been apparent in Health Catalyst (HCAT) lately with too much selling pressure. The stock has declined 21.4% over the past four weeks. However, given the fact that it is now in

Hamilton Lane (HLNE) Loses 20% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Hamilton Lane (HLNE) Loses 20% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Hamilton Lane (HLNE) has been on a downward spiral lately with significant selling pressure. After declining 20% over the past four weeks, the stock looks well positioned for a trend reversal as it

PBF Energy Q4 Earnings Beat Estimates on Higher Refining Margins
PBF Energy Q4 Earnings Beat Estimates on Higher Refining Margins

PBF Energy Inc. PBF reported a fourth-quarter 2025 adjusted earnings of 49 cents per share, which beat the Zacks Consensus Estimate of a loss of 15 cents. The bottom line also improved from the

Crypto & Blockchain Stocks to Buy as Volatility Creates Opportunities:
Crypto & Blockchain Stocks to Buy as Volatility Creates Opportunities

An updated edition of the Dec. 22, 2025 article.Cryptocurrencies such as Bitcoin, Ethereum, Solana, Cardano, Dogecoin, XRP and various stablecoins operate on decentralized blockchain networks that

Should You Buy, Hold or Sell Tempus AI Stock Pre-Q4 Earnings Release?Photo, wide shot, wide-angle lens,  Semiconductor company, sunset photo at golden hour, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/92ce44e9-64c7-4458-9a95-b706ed510490.png
Should You Buy, Hold or Sell Tempus AI Stock Pre-Q4 Earnings Release?

Tempus AI TEM is slated to release fourth-quarter 2025 results on Feb. 24, after market close. During the quarter, the company advanced several strategic collaborations and product innovations that

Madison Square Garden (MSGS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Madison Square Garden (MSGS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Madison Square Garden (MSGS) reported $403.42 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 12.8%. EPS of $0.34 for the same period compares to

Is It Worth Investing in Camtek (CAMT) Based on Wall Street's Bullish Views?
Is It Worth Investing in Camtek (CAMT) Based on Wall Street's Bullish Views?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

Wall Street Bulls Look Optimistic About CRH (CRH): Should You Buy?
Wall Street Bulls Look Optimistic About CRH (CRH): Should You Buy?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

Here's What Key Metrics Tell Us About Colliers International (CIGI) Q4 Earnings
Here's What Key Metrics Tell Us About Colliers International (CIGI) Q4 Earnings

Colliers International (CIGI) reported $1.61 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 7%. EPS of $2.34 for the same period compares to $2.26

TriNet (TNET) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
TriNet (TNET) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended December 2025, TriNet Group (TNET) reported revenue of $245 million, down 2.8% over the same period last year. EPS came in at $0.46, compared to $0.44 in the year-ago quarter.

Is Merck (MRK) a Buy as Wall Street Analysts Look Optimistic?
Is Merck (MRK) a Buy as Wall Street Analysts Look Optimistic?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)